GlassScriptPhysician profile
William Thomas Kittleman
NPI 1528060241
$2,101.72
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $254 · 2021: $198 · 2022: $331 · 2023: $272 · 2024: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $435.05 | 2022-2024 | |
| Allergan, INC. | $321.49 | 2019-2022 | |
| Alcon Vision LLC | $247.48 | 2019-2023 | Clareon |
| Biotissue Holdings INC. | $156.18 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $134.25 | 2019-2023 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $133.74 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $106.71 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $90.16 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $89.56 | 2022-2024 | Miebo, Xiidra |
| Shire North American Group INC | $73.86 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $58.46 | 2023 | Eylea Hd, Eylea |
| Novartis Pharmaceuticals Corporation | $52.49 | 2019 | |
| Dompe US, INC. | $43.47 | 2019-2024 | Oxervate |
| Apellis Pharmaceuticals, INC. | $40.49 | 2022-2024 | Syfovre |
| Carl Zeiss Meditec USA, INC. | $27.03 | 2023 | Forum |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $19.87 | 2019 | |
| Ocular Therapeutix, INC. | $19.76 | 2020 | |
| Thea Pharma INC. | $18.73 | 2022 | |
| Harrow Eye, LLC | $16.93 | 2024 | Vevye |
| Eyevance Pharmaceuticals LLC | $16.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kittleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.